DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stock Position Cut by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. trimmed its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 86.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 55,042 shares of the medical instruments supplier’s stock after selling 349,815 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in DENTSPLY SIRONA were worth $1,489,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in XRAY. Scientech Research LLC bought a new stake in DENTSPLY SIRONA during the second quarter worth approximately $846,000. VELA Investment Management LLC bought a new stake in DENTSPLY SIRONA in the third quarter worth about $2,168,000. M&G Plc acquired a new stake in DENTSPLY SIRONA in the 2nd quarter valued at about $8,817,000. Virtu Financial LLC bought a new position in shares of DENTSPLY SIRONA during the 1st quarter valued at about $1,027,000. Finally, Country Club Bank acquired a new position in shares of DENTSPLY SIRONA in the 3rd quarter worth approximately $4,084,000. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $19.19 on Wednesday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a market capitalization of $3.81 billion, a price-to-earnings ratio of -9.27, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02. The company has a 50 day simple moving average of $23.12 and a 200-day simple moving average of $24.99. DENTSPLY SIRONA Inc. has a 52-week low of $17.21 and a 52-week high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. During the same quarter in the prior year, the firm earned $0.49 EPS. The company’s revenue was up .4% compared to the same quarter last year. Equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

Analysts Set New Price Targets

XRAY has been the subject of a number of research reports. Barrington Research reduced their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, November 8th. Leerink Partnrs lowered DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Tuesday, November 19th. Needham & Company LLC decreased their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Finally, Evercore ISI cut their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Seven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Hold” and a consensus price target of $29.50.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.